Hormone receptor negative HER2 positive breast cancer

3 total trials MedDRA PT

Filter these 3 trials by phase, country, sponsor and more.

Open in Search →

Impact of EXercise on quality of life of early breast cancer patients on treatment with adjuvant Aromatase Inhibitors with or without CDK4/6 … Pending

2025-522848-40-00 6 "Early Breast Cancer"
Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients With HR+/HER2− Metastatic Breast Cancer Who Have Received … Recruitment ended

2022-502593-17-00 5 2023-09-19 "Locally advanced or metastatic hormone receptor (HR)-positiv"
Impact of 18F-FES TEP on therapeutical management in patients with metastatic breast cancer, ER positive and HER2 negative, in relapse after … Ended

2024-517400-11-00 6 2024-10-24 "Patients with metastatic breast cancer initially presenting "

Showing 1–3 of 3 trials